Post-treatment remnant cancer cells undermine immune system to cause relapse: Latest study shows
A new study concluded that the residual cancer cells that survived the initial anticancer treatment could exploit our immune system leading to cancer recurrence. The study, jointly-funded by European Research Council, the Richard M Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, and the US National Institutes of Health was recently published in the journal of Cancer Immunology Research. The study was carried out in mice where researchers investigated…